Literature DB >> 17351692

Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy.

Paolo Manganotti1, Fabio Zaina, Maurizio Falso, Franco Milanese, Antonio Fiaschi.   

Abstract

OBJECTIVE: To develop a clinical and instrumental protocol to assess the postural and dynamic effects following treatment with botulinum neurotoxin A in children with cerebral palsy affected by spastic equinus.
DESIGN: Open study, in which every patient served as his or her own control. PATIENTS: Ten sequential children with cerebral palsy and spastic dynamic equinus foot.
METHODS: Botulinum neurotoxin A was injected in the gastrocnemius, soleus and tibialis posterior muscles. The main measures were: pedobarometry, dynamic surface electromyography, video gait analysis scale, and the modified Ashworth Scale.
RESULTS: After treatment with botulinum neurotoxin A, pedobarometric evaluation revealed a significant change in all parameters, including a decrease in the modified Ashworth Scale and an increase in the range of motion. All children showed significant improvement in initial foot contact, as documented by the video gait analysis scale. The calf muscle electromyography pattern showed a decrease in co-contraction during gait in all children. These modifications were statistically significant for all parameters considered (p < 0.05).
CONCLUSION: This pilot study suggests that dynamic electromyography and pedobarometry are simple to use and provide useful data; this protocol could be preferable in young and uncooperative children in order to monitor rehabilitation treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351692     DOI: 10.2340/16501977-0036

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  3 in total

Review 1.  [Spastic equinus foot].

Authors:  B Westhoff; K Weimann-Stahlschmidt; R Krauspe
Journal:  Orthopade       Date:  2011-07       Impact factor: 1.087

2.  Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.

Authors:  Ece Unlu; Alev Cevikol; Burcu Bal; Emel Gonen; Ozlem Celik; Gulşen Kose
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

3.  Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.

Authors:  Ja Young Choi; Soojin Jung; Dong Wook Rha; Eun Sook Park
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.